In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.

The in vitro and in vivo activities of a new benzoxazinorifamycin, KRM-1648 (KRM), against Mycobacterium tuberculosis were studied. The MIC at which 50% of the isolates are inhibited (MIC50) and the MIC90 of KRM for 30 fresh isolates of M. tuberculosis measured by the BACTEC 460 TB System were 0.016...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Hirata, T, Saito, H, Tomioka, H, Sato, K, Jidoi, J, Hosoe, K, Hidaka, T
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1995
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162932/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8619585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.10.2295
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!